Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes
Radu Ionescu, Yoav Broza, Hila Shaltieli, Dvir Sadeh, Yael Zilberman, Xinliang Feng, Lea Glass-Marmor, Izabella Lejbkowicz, Klaus Müllen, Ariel Miller, Hossam Haick, Radu Ionescu, Yoav Broza, Hila Shaltieli, Dvir Sadeh, Yael Zilberman, Xinliang Feng, Lea Glass-Marmor, Izabella Lejbkowicz, Klaus Müllen, Ariel Miller, Hossam Haick
Abstract
A cross-reactive array of polycyclic aromatic hydrocarbons and single wall carbon nanotube bilayers was designed for the detection of volatile organic compounds (tentatively, hexanal and 5-methyl-undecane) that identify the presence of disease in the exhaled breath of patients with multiple sclerosis. The sensors showed excellent discrimination between hexanal, 5-methyl-undecane, and other confounding volatile organic compounds. Results obtained from a clinical study consisting of 51 volunteers showed that the sensors could discriminate between multiple sclerosis and healthy states from exhaled breath samples with 85.3% sensitivity, 70.6% specificity, and 80.4% accuracy. These results open new frontiers in the development of a fast, noninvasive, and inexpensive medical diagnostic tool for the detection and identification of multiple sclerosis. The results could serve also as a launching pad for the discrimination between different subphases or stages of multiple sclerosis as well as for the identification of multiple sclerosis patients who would respond well to immunotherapy.
Keywords: Multiple sclerosis; biomarker; breath; carbon nanotube; diagnosis; polycyclic aromatic hydrocarbon.
Figures
Source: PubMed